The prognostic impact of septal myectomy in obstructive hypertrophic cardiomyopathy.

The prognostic impact of septal myectomy in obstructive hypertrophic cardiomyopathy.

Bibliographic Details
Main Authors:	Watkins, H, McKenna, W
Format:	Journal article
Language:	English
Published:	2005

Similar Items

Transapical Approach to Septal Myectomy for Hypertrophic Cardiomyopathy
by: Alexander Afanasyev, et al.
Published: (2024-01-01)

Mitral valve repair during septal myectomy in obstructive hypertrophic cardiomyopathy
by: Sergei A. Budagaev, et al.
Published: (2023-07-01)

Effects of surgical septal myectomy on survival in patients with hypertrophic obstructive cardiomyopathy
by: Xiangbin Meng, et al.
Published: (2020-05-01)

Septal Reduction Therapy for Obstructive Hypertrophic Cardiomyopathy: Volume Still Matters for Septal Myectomy
by: Vincent Y. See, et al.
Published: (2023-05-01)

Surgery for Hypertrophic Obstructive Cardiomyopathy: Comprehensive LVOT Management beyond Septal Myectomy
by: Alessandro Affronti, et al.
Published: (2021-09-01)

Surgical septal myectomy versus septal alcohol ablation for hypertrophic obstructive cardiomyopathy: a continuing debate
by: S Meditskou, et al.
Published: (2008-05-01)

Effects of septal myectomy on left atrial and left ventricular function in obstructive hypertrophic cardiomyopathy
by: Kyung Eun Ha, et al.
Published: (2023-10-01)

Left ventricular remodeling following septal myectomy in hypertrophic obstructive cardiomyopathyCentral MessagePerspective
by: Tsuyoshi Yamabe, MD, et al.
Published: (2022-09-01)

Alcohol Septal Ablation or Septal Myectomy? An Updated Systematic Review and Meta-Analysis of Septal Reduction Therapy for Hypertrophic Obstructive Cardiomyopathy
by: Xifeng Zheng, et al.
Published: (2022-05-01)

Alcohol Septal Ablation versus Septal Myectomy Treatment of Obstructive Hypertrophic Cardiomyopathy: A Systematic Review and Meta-Analysis
by: Ibadete Bytyçi, et al.
Published: (2020-09-01)

Computational fluid dynamics may aid in pre-operative planning of septal myectomy in obstructive hypertrophic cardiomyopathy
by: Wenqian Wu, et al.
Published: (2023-03-01)

Association of Preoperative Sleep-Disordered Breathing With Functional Status After Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy
by: Daokun Sun, MD, MPH, et al.
Published: (2022-10-01)

Midterm Outcome After Septal Myectomy and Medical Therapy in Mildly Symptomatic Patients With Hypertrophic Obstructive Cardiomyopathy
by: Jiejun Sun, et al.
Published: (2022-03-01)

Clinical Effect of the Modified Morrow Septal Myectomy Procedure for Biventricular Hypertrophic Cardiomyopathy
by: Tong Tan, et al.
Published: (2024-01-01)

Septal Myectomy and Subvalvular Repair in Hypertrophic Cardiomyopathy, a Systematic Review and Pooled Analysis
by: Ming-Yang Song, et al.
Published: (2023-09-01)

Evidence from human myectomy samples that MYBPC3 mutations cause hypertrophic cardiomyopathy through haploinsufficiency.
by: Marston, S, et al.
Published: (2009)

Assessment of safety and efficacy of Morrow septal myectomy and alcohol septal ablation in patients with obstructive hypertrophic cardiomyopathy: the results of a pilot randomized trial
by: Р. А. Найденов, et al.
Published: (2016-11-01)

Impact of Body Mass Index on Postoperative Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy Undergoing Septal Myectomy
by: Jian Zhang, et al.
Published: (2022-02-01)

Hypertrophic obstructive cardiomyopathy caused by Fabry disease: implications for surgical myectomy
by: Andrea Frustaci, et al.
Published: (2023-12-01)

Reverse remodeling of left atrium assessed by cardiovascular magnetic resonance feature tracking in hypertrophic obstructive cardiomyopathy after septal myectomy
by: Shujuan Yang, et al.
Published: (2023-02-01)

The Risk of Ventricular Arrhythmias between Alcohol Septal Ablation and Septal Myectomy in Hypertrophic Cardiomyopathy: A Meta-Analysis on Septal Reduction Therapy
by: Wei Tang, et al.
Published: (2022-11-01)

Resultados a longo prazo da miectomia septal no tratamento da cardiomiopatia hipertrófica Long term results of septal myectomy in the treatment of obstructive hypertrophic cardiomyopathy
by: Luiz Augusto Ferreira Lisboa, et al.
Published: (2011-03-01)

Endocardial septal ablation for hypertrophic obstructive cardiomyopathy
by: Tolga Aksu, et al.
Published: (2017-01-01)

Improvement in coronary microvascular dysfunction evaluated by cardiac magnetic resonance in patients with hypertrophic obstructive cardiomyopathy after transapical beating-heart septal myectomy
by: Yun Zhao, et al.
Published: (2023-10-01)

The genetics of hypertrophic cardiomyopathy: Teare redux.
by: Watkins, H, et al.
Published: (2008)

Clinical outcomes of septal myectomy in hypertrophic cardiomyopathy with refractory symptoms: A single institutional experience from India
by: Revanth Maramreddy, et al.
Published: (2023-11-01)

Targeting Alcohol Septal Ablation in Patients with Obstructive Hypertrophic Cardiomyopathy Candidates for Surgical Myectomy: Added Value of Three-Dimensional Intracoronary Myocardial Contrast Echocardiography
by: Giovanni La Canna, et al.
Published: (2021-05-01)

Alcohol Septal Ablation or Mavacamten for Obstructive Hypertrophic Cardiomyopathy
by: Smita Scholtz, et al.
Published: (2023-10-01)

Disease pathways and novel therapeutic targets in hypertrophic cardiomyopathy.
by: Ashrafian, H, et al.
Published: (2011)

Transaortic Shallow Septal Myectomy and Cutting of Secondary Fibrotic Mitral Valve Chordae—A 5-Year Single-Center Experience in the Treatment of Hypertrophic Obstructive Cardiomyopathy
by: Lucian Florin Dorobantu, et al.
Published: (2022-05-01)

Maintenance of Subcutaneous Implantable Cardioverter Defibrillators in Hypertrophic Cardiomyopathy Patients With Iatrogenic Left Bundle‐Branch Block After Septal Myectomy
by: Chockalingam A. Narayanan, et al.
Published: (2024-04-01)

Analysis of electrocardiographic signs in hypertrophic cardiomyopathy before and after septal myectomy. New criterion for proximal left bundle branch block
by: L. M. Malishevsky, et al.
Published: (2022-08-01)

Alcohol Septal Ablation: An Option on the Rise in Hypertrophic Obstructive Cardiomyopathy
by: Victor Arévalos, et al.
Published: (2021-05-01)

Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: focus on safety
by: J Veselka
Published: (2007-12-01)

Outcomes in Patients With Obstructive Hypertrophic Cardiomyopathy and Concomitant Aortic Stenosis Undergoing Surgical Myectomy and Aortic Valve Replacement
by: Milind Y. Desai, et al.
Published: (2021-09-01)

Future Role of New Negative Inotropic Agents in the Era of Established Surgical Myectomy for Symptomatic Obstructive Hypertrophic Cardiomyopathy
by: Barry J. Maron, et al.
Published: (2022-05-01)

Impact of Race and Ethnicity on Use and Outcomes of Septal Reduction Therapies for Obstructive Hypertrophic Cardiomyopathy
by: Sri Harsha Patlolla, et al.
Published: (2023-01-01)

Association between postoperative nadir platelet count and postoperative cardiovascular complications following septal myectomy in patients with hypertrophic cardiomyopathy: a retrospective cohort study
by: Qianqian Fan, et al.
Published: (2024-01-01)

Effect of metoprolol in hypertrophic obstructive cardiomyopathy patients after alcohol septal ablation
by: Hana Hnátová, et al.
Published: (2023-12-01)

Alcohol Septal Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy: A Contemporary Perspective
by: Felice Gragnano, et al.
Published: (2023-04-01)